Melatonin levels and markers of acute kidney injury in acute coronary syndrome


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Purpose. To identify features of melatonin (MT) levels and its relationship with serum creatinine and neutrophil gelatinase associated lipocalin (NGAL) levels in patients with acute coronary syndrome (Acs). Materials and methods. In 146 patients with ACS and in 26 patients with stable angina (SA) of II-III clinical functional class, urine was collected on 1-3 days of hospitalization from 2,300 to 800 and from 800 to 2,300, and the content of MT metabolite (ng/ml) was determined using high performance liquid chromatography. In all patients fasting venous blood was sampled with the definition of creatinine (sCr1) (mmol/l) on 1-3 day of hospitalization using colorimetric method, with redetermination of sCr2 levels in patients with ACS at 24-72 h. In 78 patients with ACS and in 9 patients with SA, NGAL levels (ng / ml) in the blood (s-NGAL) and urine (u-NGAL) were determined on 1-3 day hospitalization using ELISA. Results. Daily rhythm of MT secretion was preserved in patients with SA (0.31 and 0.26); in contrast, in patients with ACS it was disturbed (0.26 and 0.42). Acute kidney injury (AKI) according to the creatinine levels was diagnosed in 35 patients with ACS. s-NGAL levels more than 177 ng/ml were diagnosed in 48 patients with ACS, u-NGAL levels more than 72 ng/ml - in 7 patients with ACS. Cardiovascular complications were diagnosed in 52% of patients with early (predicted) AKI and in 80% of patients with late (dynamic) AKI. Conclusion. MT, creatinine and NGAL levels can be used as an additional diagnostic criteria for predicting the course of hospital stage of ACS.

Full Text

Restricted Access

References

  1. Комаров Ф.И., Рапопорт С.И., Малиновская Н.К. и др. Мелатонин в норме и патологии. - М.: ИД«МЕДПРАКТИКА-М». - 2004.
  2. Беспятых А.Ю., Бродский В.Я., Бурлакова О.В. и др. Мелатонин: теория и практика. - М.: ИД «МЕДПРАКТИКА-М». - 2009.
  3. Хронобиология и хрономедицина: Руководство / Под ред. С.И. Рапопорта, В.А. Фролова, Л.Г. Хетагуровой. - М.: ООО «Медицинское информационное агентство». - 2012.
  4. Acute Kidney Injury In Emergency Cases - Using Biomarkers // Journal of the American College of Cardiology. - 2012. - Vol. 1. - P. 12.
  5. Cruz D.N., Gaiao S., Maisel A. et al. Neutrophilgelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review // Clin Chem Lab Med. - 2012. - Vol. 50(9). - P. 1533-45.
  6. Helánová K., Pařenica J., Dlouhý V. et al. The importance of NGAL and cystatin C biomarkers in cardiovascular diseases // Vnitr Lek. - 2012. - Vol. 58(4). - P. 286-90.
  7. Sener G., Sehirli A.O., Keyer-Uysal M. et al. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat // J Pineal Res. - 2002. - Vol. 32. - P. 120-126.
  8. Национальные клинические рекомендации. Сборник / Под ред. Р.Г. Оганова. - 3-е изд. - М.: Изд-во «Силицея-Полиграф». - 2010.
  9. Смирнов А.В., Шилов Е.М., Добронравов В.А. и др. Национальные рекомендации. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. - СПб.: Левша. -2012.
  10. Ардашев В.Н., Каленова И.Е., Ляпкова Н.Б. и соавт. Доказательная медицина: обзор современных математических методов анализа: Монография. - М. : АВН, УНМЦ УД Президента РФ. - 2013.
  11. Latchamsetty R., Fang J., Kline-Rogers E. et al. Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome // Am J Cardiol. - 2007. - Vol. 99(7). -P. 939-42.
  12. Berl T., Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment // Clin J Am Soc Nephrol. - 2006. - Vol. 1. - P. 8-18.
  13. Fox C.S., Muntner P., Chen A.Y. et al. Short-term outcomes of acute myocardial infarction in patients with acute kidney injuri: a report from the national cardiovascular data registry // Circulation. - 2012. - Vol. 125(3). - P. 497-504.
  14. Мензоров М.В., Шутов А.М., Макеева Е.Р. и соавт. Сложности диагностики острого повреждения почек у больных инфарктом миокарда с подъемом сегмента ST // Тер. архив. - 2014. - № 4. - С. 25-29.
  15. Белохвостикова Т.С., Орлова Г.М., Фатахова О.А. и др. Липокалин, ассоциированный с желатиназой нейтрофилов, у больных хронической болезнью почек: клинико-лабораторные взаимосвязи // Нефрология и диализ. - 2011. - № 3. - С. 268-69.
  16. Мензоров М.В., Шутов А.М. Липокалин, ассоциированный с желатиназой нейтрофилов, в прогнозировании острого повреждения почек у больных с острым коронарным синдромом // Клин. мед. - 2014. - № 3. - С. 54-58.
  17. Кобалава Ж.Д., Виллевальде С.В., Ефремовцева М.А. и др. Биомаркеры острого повреждения почек: современные представления и перспективы // Тер. архив. - 2014. - № 6. - С. 88-93.
  18. Макеева Е.Р., Мензоров М.В., Шутов А.М. и др. Влияние острого повреждения почек на прогноз больных острой декомпенсацией хронической сердечной недостаточности // Сердечная недостаточность. - 2014. - № 82(1). - С. 32-38.
  19. Clerico A., Galli C., Fortunato A. et al. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injuri: a review of the laboratory characteristics and clinical evidences // Clin. Chem. Lab. Med. - 2012. - Vol. 50(9). - P. 1505-17.
  20. Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injuri // Biomark. Med. - 2010; April. - Vol. 4(2). - P. 89-94.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies